Inflammatory Markers Guide
Chronic low-grade inflammation is the common thread running through cardiovascular disease, insulin resistance, metabolic syndrome, cognitive decline, and accelerated aging. These markers measure your body's inflammatory load — and they are among the clearest, most actionable signals that your program is working at the cellular level.
High-Sensitivity CRP (hs-CRP) — Your Inflammation Thermostat
C-Reactive Protein (CRP) is produced by the liver in response to inflammatory signals from damaged tissue, infections, and — most relevant to your program — the chronic low-grade inflammatory activity of excess visceral body fat. High-sensitivity CRP (hs-CRP) is the most clinically validated, widely available marker of systemic inflammation, and it is the marker the American College of Cardiology now formally recognizes as a therapeutic target alongside LDL cholesterol for cardiovascular risk management.
The distinction between standard CRP and hs-CRP is critical: a standard CRP test cannot detect inflammation below approximately 3–5 mg/L, missing the subtle chronic inflammatory load that drives cardiovascular disease, metabolic dysfunction, and accelerated aging. The hs-CRP test measures concentrations as low as 0.3 mg/L — making it the essential tool for prevention-focused care. Always confirm your report says "high-sensitivity" CRP — a normal standard CRP does not rule out clinically meaningful chronic inflammation.
| Category | hs-CRP Level | Clinical Meaning |
|---|---|---|
| Wellness-Optimal | < 0.5 mg/L | Lowest cardiovascular risk and inflammatory burden. Large-scale studies confirm significantly lower rates of cardiovascular events, cognitive decline, and metabolic disease at this level. The PYW target. |
| Low Risk | 0.5–1.0 mg/L | Excellent range. Low systemic inflammation. Continue all program protocols. |
| Moderate Risk | 1.0–3.0 mg/L | Conventional medicine considers this "acceptable." Functional medicine recognizes this range as representing real, ongoing chronic inflammation contributing quietly to disease. Protocol action recommended. |
| High Risk | 3.0–10.0 mg/L | Significant systemic inflammation. Elevated cardiovascular, metabolic, and all-cause mortality risk. Direct physician review and protocol intensification required. |
| Acute Inflammation / Infection | > 10.0 mg/L | This level typically reflects acute infection, injury, or flare of inflammatory disease — not chronic low-grade inflammation. Do not test during illness. Retest when fully recovered. |
hs-CRP is one of the most responsive biomarkers to the combined interventions of your PYW program. Most members with elevated hs-CRP see a 30–60% reduction with comprehensive protocol adherence. Here is what drives it:
- Visceral fat reduction: The single most impactful driver. Visceral adipose tissue (VAT) secretes IL-6 and TNF-alpha continuously. As VAT decreases, so does the liver's production of CRP — often dramatically. The NEJM cardiovascular outcomes trial documented a 31% reduction in CRP among members in sustained metabolic programs.
- Omega-3 fatty acids (salmon, walnuts, fish oil): Directly reduce inflammatory cytokines at the cellular level. Aim for 2–3 servings of fatty fish per week or supplement with 2–3g EPA+DHA daily.
- Resistance training: Muscle tissue releases anti-inflammatory myokines during contraction. Regular resistance training produces a sustained anti-inflammatory effect that reduces baseline hs-CRP over 8–12 weeks.
- Quality sleep: Sleep deprivation elevates IL-6 and TNF-alpha — the same cytokines that drive CRP production. Consistently reaching 7–8 hours of quality sleep is a direct anti-inflammatory intervention.
- Reducing refined carbohydrates and added sugar: Post-meal glucose spikes trigger inflammatory cytokine release. Protein-first eating and reduced refined carbs lower the daily inflammatory stimulus from meals.
- Stress reduction: Chronic psychological stress elevates cortisol, which paradoxically promotes inflammatory gene expression over time. Consistent stress management practice directly lowers hs-CRP.
If your hs-CRP is elevated, identifying the primary driver determines the most effective intervention. Most common causes in metabolic program members:
- Excess visceral body fat: The most common driver. VAT is metabolically active inflammatory tissue. Reduction of visceral fat is the primary intervention.
- Poor sleep (chronic): Even one week of under-7-hour sleep raises inflammatory markers measurably. This is one of the most underappreciated contributors to elevated hs-CRP.
- High refined carbohydrate and sugar intake: Each post-meal glucose spike triggers a transient inflammatory response. Frequent spikes maintain chronically elevated inflammation.
- Sedentary behavior: Lack of regular movement removes the muscle's anti-inflammatory myokine output. Even moderate daily walking lowers CRP measurably over 12 weeks.
- Chronic stress and elevated cortisol: Paradoxically, while cortisol has acute anti-inflammatory effects, chronic elevation promotes pro-inflammatory gene expression.
- Periodontal (gum) disease: Often overlooked. Oral bacterial infection is one of the most common and modifiable drivers of elevated hs-CRP. Annual dental cleaning and consistent oral hygiene matter.
- Alcohol consumption: Directly pro-inflammatory. Suppresses fat oxidation and elevates hepatic inflammatory markers for 24+ hours after each drinking episode.
- Smoking: One of the strongest independent drivers of elevated hs-CRP. A single cigarette produces measurable CRP elevation.
Homocysteine — The Silent Vascular Risk Marker
Homocysteine is an amino acid produced as a byproduct of methionine metabolism — specifically from the breakdown of proteins in the diet. Unlike most inflammatory markers, elevated homocysteine is not produced by inflammatory tissue itself. Instead, it is a direct measure of how well your body methylates and processes certain B vitamins — and when this process is impaired, homocysteine accumulates and causes direct vascular injury, promotes oxidative stress, and drives systemic inflammation independently of other risk factors.
Elevated homocysteine damages endothelial cells (the lining of blood vessels), promotes atherosclerotic plaque formation, increases blood clot risk, and crosses the blood-brain barrier where it contributes to neuroinflammation and cognitive decline. Research shows that every 5 μmol/L increase in homocysteine is associated with a 33.6% increase in all-cause mortality — making it one of the most clinically significant markers you can optimize, and one of the most responsive to simple nutritional intervention.
| Category | Range | Clinical Meaning |
|---|---|---|
| Wellness-Optimal | 4–7 μmol/L | Lowest vascular and neurological risk. Strong methylation capacity. The PYW target. Research consistently shows meaningfully better outcomes at this level versus the standard "normal." |
| Good | 7–9 μmol/L | Still in a favorable range. Some room for optimization through B vitamin support. Monitor trend direction quarterly. |
| Borderline Elevated | 9–12 μmol/L | Standard labs often report this as "normal." Research shows that 9.8 μmol/L or higher is associated with a 28% greater risk of all-cause mortality. Protocol action recommended. |
| Elevated | 12–15 μmol/L | Meaningful vascular and neurological risk. Investigate B12, folate, and B6 status. MTHFR gene variant testing may be indicated. Physician review warranted. |
| High — Action Required | > 15 μmol/L | Significant hyperhomocysteinemia. Substantially elevated cardiovascular and neurological risk. Direct physician review and intervention required. |
Homocysteine is one of the most nutrient-responsive biomarkers available — elevated levels are almost always correctable with targeted B vitamin supplementation. The three critical vitamins in the methylation pathway that processes homocysteine are:
- Folate (B9): The most important methylation cofactor for homocysteine processing. Found in leafy greens, lentils, and beans. Supplement with methylfolate (not folic acid) at 400–800 μg/day — especially important for members with the MTHFR gene variant, which impairs folic acid conversion.
- Vitamin B12 (methylcobalamin): Works in tandem with folate in the methylation cycle. B12 deficiency is common in people eating lower quantities of animal protein and in adults over 50 (reduced gastric acid impairs absorption). Supplement with methylcobalamin 1000 μg/day if dietary intake is limited.
- Vitamin B6 (pyridoxine): Required for the alternative pathway of homocysteine metabolism. Found in chicken, fish, potatoes, and bananas. Most people on a protein-adequate diet get sufficient B6, but supplementation is often included in B-complex formulas.
- Betaine (TMG — trimethylglycine): An alternative methyl donor that can lower homocysteine through a separate pathway independent of folate. Particularly useful for members with MTHFR variants or those who do not respond adequately to B vitamins alone. 1–3g/day.
- Most members see homocysteine normalize within 8–12 weeks of adequate B vitamin supplementation. Retest at the next quarterly panel to confirm response.
- Endothelial injury: Homocysteine directly damages the cells lining your blood vessels — creating micro-injuries that attract inflammatory cells and accelerate atherosclerotic plaque formation even at "normal" conventional levels.
- Oxidative stress amplification: Homocysteine auto-oxidizes in the bloodstream, producing free radicals that damage lipoproteins (oxidized LDL is the most atherogenic form) and accelerate cellular aging.
- Neuroinflammation: Homocysteine crosses the blood-brain barrier and promotes neuroinflammatory pathways linked to cognitive decline, depression, and increased Alzheimer's risk. This is one of the most important non-cardiovascular reasons to maintain optimal homocysteine levels.
- Increased clot risk: Elevated homocysteine impairs anticoagulation proteins and promotes a hypercoagulable (clot-prone) state — increasing the risk of deep vein thrombosis, pulmonary embolism, and stroke.
- Bone density reduction: Homocysteine interferes with collagen crosslinking in bone matrix, reducing structural bone integrity and increasing fracture risk independently of calcium and vitamin D status.
- MTHFR gene variant: Approximately 40–60% of the population carries a common variant of the MTHFR gene that impairs folate processing. If your homocysteine is elevated despite adequate dietary folate, ask your physician about MTHFR testing and methylfolate supplementation.
Ferritin — Iron Storage Protein and Inflammation Signal
Ferritin is the body's primary iron storage protein — but it is not simply an iron marker. Ferritin is also an acute-phase reactant, meaning the liver produces more of it in response to inflammation, infection, and metabolic stress. This dual role makes ferritin interpretation nuanced: elevated ferritin can signal either excess iron storage, chronic inflammation, or both simultaneously. Low ferritin, on the other hand, almost always indicates iron depletion — a common and frequently missed cause of fatigue, exercise intolerance, poor recovery, and cognitive difficulty on weight management programs.
For wellness-focused patients, ferritin is most usefully interpreted alongside hs-CRP: elevated ferritin with elevated CRP suggests inflammation-driven ferritin elevation (iron storage may be adequate). Elevated ferritin with normal CRP is more likely to reflect true iron excess, which carries its own metabolic risks. Low ferritin regardless of CRP indicates genuine iron depletion.
| Category | Men | Women | Clinical Meaning |
|---|---|---|---|
| Wellness-Optimal | 75–150 ng/mL | 50–100 ng/mL | Adequate iron storage. Supports oxygen delivery to exercising muscle, cognitive function, immune defense, and energy production. The PYW target. |
| Low-Normal | 30–74 ng/mL | 20–49 ng/mL | Technically within standard range but functionally suboptimal. Fatigue, exercise intolerance, and hair thinning can occur at these levels despite a "normal" result. |
| Iron Depletion | < 30 ng/mL | < 20 ng/mL | Iron-depleted state. Pre-anemia. Exercise recovery impaired, fatigue significant, cognitive difficulty common. Iron supplementation and dietary intervention indicated. |
| Elevated (with high CRP) | > 200 ng/mL | > 150 ng/mL | If CRP is also elevated, this likely reflects inflammation-driven ferritin rather than true iron excess. The primary target is reducing inflammation. |
| Elevated (with normal CRP) | > 300 ng/mL | > 200 ng/mL | Potential iron excess. Associated with oxidative stress, liver damage, and metabolic syndrome. Physician review required. Do not supplement iron at these levels. |
Low ferritin is more common on weight management programs than most members realize, for several reasons specific to this context:
- Reduced red meat consumption: Most PYW nutrition protocols emphasize lean proteins, which may reduce heme iron intake (the most bioavailable form). If red meat is significantly reduced, iron needs monitoring.
- Increased exercise demand: As exercise intensity and frequency increase on your program, iron demand rises (iron is essential for hemoglobin oxygen delivery to working muscle). This can deplete stores faster than dietary intake replaces them.
- GLP-related changes in gastric acid: GLP-based metabolic therapy slows gastric emptying, which can affect the acidic environment needed for optimal iron absorption. This does not affect all members but is worth monitoring.
- In women: menstrual blood loss: Premenopausal women lose iron with each menstrual cycle. On a caloric-deficit program where dietary iron may be reduced, this can accelerate ferritin depletion.
- Symptoms of low ferritin: Unexplained fatigue disproportionate to activity level, exercise intolerance, poor workout recovery, hair thinning or shedding, brain fog, shortness of breath with exertion, restless legs at night. If these symptoms are present and ferritin is below 50 ng/mL, discuss iron supplementation with your physician before attributing symptoms to the program itself.
If your ferritin is elevated and hs-CRP is also elevated, the primary intervention is reducing systemic inflammation — which will lower the liver's ferritin production as a downstream consequence. The interventions that lower hs-CRP also lower inflammation-driven ferritin:
- Visceral fat reduction: The strongest driver of inflammation-associated ferritin elevation. As visceral fat decreases on your program, inflammatory cytokine output falls and ferritin normalizes.
- Alcohol elimination: Alcohol is a direct hepatic toxin that elevates liver-produced inflammatory proteins including ferritin. Eliminating alcohol produces measurable reductions in ferritin within 4–6 weeks.
- Reducing refined iron sources: If ferritin is elevated with normal CRP (true iron excess), reduce red meat to 1–2 servings per week, avoid supplemental iron, and avoid cast-iron cookware for high-acid foods.
- Regular blood donation: For men and postmenopausal women with chronically elevated ferritin and no identifiable inflammatory driver, regular blood donation is the most effective method of reducing iron stores. Discuss with your physician.
- Monitor the CRP-ferritin relationship: At each quarterly panel, interpret these two markers together. Falling CRP alongside falling ferritin confirms the inflammation-reduction strategy is working. Falling CRP with persistently elevated ferritin warrants further investigation.
Immune Markers — Reading Your Complete Blood Count
Your Complete Blood Count (CBC) is one of the most information-dense tests in your quarterly panel. Beyond counting red and white blood cells, it reveals the balance and character of your immune system — providing important signals about systemic inflammation, immune competence, and overall health trajectory. Several CBC-derived ratios have emerged as particularly powerful inflammatory and prognostic indicators that most standard lab interpretations completely ignore.
Total white blood cells (WBC) count all circulating immune cells. The differential breaks this down into five subtypes, each with distinct functions and inflammatory significance.
| WBC Component | Standard Range | Wellness-Optimal | What Elevation or Reduction Means |
|---|---|---|---|
| Total WBC | 4.5–11.0 K/μL | 4.5–7.5 K/μL | Total WBC in the upper portion of the standard range (7.5–11.0) is associated with chronic inflammation and metabolic syndrome. Elevated WBC without infection is a meaningful inflammatory signal. Lower within-range WBC is associated with better metabolic outcomes. |
| Neutrophils | 1.8–7.7 K/μL | 1.8–4.5 K/μL | First responders to infection and tissue injury. Chronic elevation without active infection indicates ongoing inflammatory stimulus — often from visceral fat or metabolic stress. |
| Lymphocytes | 1.0–4.8 K/μL | 1.5–3.5 K/μL | Adaptive immune cells. Low lymphocytes suggest immune suppression from chronic stress, nutrient deficiency, or systemic inflammation overwhelming regulatory capacity. |
| Monocytes | 0.2–0.95 K/μL | 0.2–0.7 K/μL | Elevated monocytes are a strong signal of chronic inflammatory activation. They are recruited by visceral fat and drive macrophage infiltration in adipose tissue — one of the mechanisms by which obesity drives systemic inflammation. |
| Eosinophils | 0.05–0.5 K/μL | 0.05–0.35 K/μL | Elevated eosinophils suggest allergic processes, parasitic infection, or environmental reactivity. Mildly elevated eosinophils in metabolic program members often reflect food sensitivities or environmental allergen exposure worth investigating. |
The NLR is calculated by dividing your neutrophil count by your lymphocyte count. It is one of the most clinically powerful inflammatory ratios derived from a routine CBC, and it is almost never automatically reported. The NLR captures the balance between the pro-inflammatory arm of the immune system (neutrophils) and the anti-inflammatory, adaptive arm (lymphocytes). When this balance tips toward neutrophil dominance, it reflects a systemic inflammatory state that is independently associated with cardiovascular events, insulin resistance, and all-cause mortality.
To calculate yours: Divide your neutrophil count by your lymphocyte count. Example: Neutrophils 3.8 ÷ Lymphocytes 1.9 = NLR of 2.0 (good range)
| NLR Score | Category | Clinical Meaning |
|---|---|---|
| 1.0–1.9 | Optimal | Excellent immune balance. Low systemic inflammation. Strong adaptive immune function relative to innate inflammatory activity. |
| 2.0–2.5 | Good | Functional range. Research shows a population NLR median of approximately 2.1. Within healthy range with room to optimize. |
| 2.5–3.5 | Elevated | Borderline elevated inflammatory load. Associated with metabolic syndrome, visceral adiposity, and early cardiovascular risk. Protocol intervention recommended. |
| > 3.5 | High Concern | Significantly elevated. Strongly associated with insulin resistance, cardiovascular events, and all-cause mortality in population studies. Physician review required. |
ESR measures how quickly red blood cells settle to the bottom of a test tube over one hour. When inflammation is present, fibrinogen and other acute-phase proteins increase in the blood — causing red blood cells to clump together (rouleaux formation) and settle faster. ESR reflects the overall inflammatory protein environment more broadly than hs-CRP, making the two complementary tests.
| Category | Men | Women | Clinical Meaning |
|---|---|---|---|
| Wellness-Optimal | 0–10 mm/hr | 0–12 mm/hr | Minimal systemic inflammatory protein environment. Excellent baseline. |
| Acceptable | 11–15 mm/hr | 13–20 mm/hr | Low-to-moderate inflammatory protein environment. Monitor trend direction. Standard reference allows higher values, but wellness-focused targets are tighter. |
| Elevated | 16–30 mm/hr | 21–40 mm/hr | Significant systemic inflammation. Investigate alongside hs-CRP and clinical symptoms. Often elevated in metabolic syndrome, autoimmune activity, or occult infection. |
| High — Investigate | > 30 mm/hr | > 40 mm/hr | Substantially elevated. Warrants physician investigation for underlying inflammatory, infectious, or autoimmune drivers. |
The Comprehensive Metabolic Panel — Liver, Kidney & Beyond
Your Comprehensive Metabolic Panel (CMP) measures 14 biomarkers of organ function, electrolyte balance, and metabolic chemistry. It is not primarily an inflammatory panel — but it is essential context for interpreting your inflammatory markers, because chronic inflammation affects organ function, and organ dysfunction produces secondary inflammation. Your CMP tells your physician whether your liver, kidneys, and metabolic chemistry are working in your favor or creating additional inflammatory burden.
The liver produces CRP, processes inflammatory mediators, and detoxifies the byproducts of fat metabolism. Liver health is directly connected to your inflammatory load — and to the success of your fat loss program.
| Marker | Wellness-Optimal | Standard Reference | What Elevation Means |
|---|---|---|---|
| ALT (Alanine Aminotransferase) | < 25 U/L | < 56 U/L | Most specific marker of liver cell injury. Elevated ALT on a fat loss program can reflect either fatty liver improvement (transient elevation as liver fat is mobilized) or alcohol-related injury. Standard upper limit of 56 U/L is far above wellness-optimal. |
| AST (Aspartate Aminotransferase) | < 25 U/L | < 40 U/L | Elevated in both liver and muscle injury. After intense resistance training, AST can temporarily rise due to muscle fiber breakdown — not liver damage. The ALT/AST ratio helps distinguish the source. |
| GGT (Gamma-Glutamyl Transferase) | < 20 U/L | < 45 U/L | Most sensitive marker of alcohol-related liver stress and oxidative stress. Often the earliest signal of fatty liver disease. Standard upper limit dramatically exceeds wellness-optimal. Responds quickly to alcohol elimination and improved metabolic health. |
The kidneys filter inflammatory proteins and metabolic waste products. For members on high-protein programs, kidney function monitoring is clinically relevant — though current evidence confirms that high protein intake (up to 2.2g/kg) does not impair kidney function in healthy individuals without pre-existing kidney disease.
| Marker | Wellness-Optimal | Standard Reference | Key Note for Program Members |
|---|---|---|---|
| Creatinine | 0.7–1.1 mg/dL (W) / 0.8–1.2 mg/dL (M) | 0.6–1.2 mg/dL | Creatinine rises transiently after intense resistance training — not a sign of kidney stress. If creatinine is elevated alongside low eGFR, hydration status should be assessed first. |
| BUN (Blood Urea Nitrogen) | 7–18 mg/dL | 7–25 mg/dL | BUN rises with high protein intake and dehydration — both common on metabolic programs. If elevated, assess hydration adequacy (the 100+ oz daily water target in your nutrition guide applies here). |
| eGFR (Estimated GFR) | > 90 mL/min/1.73m² | > 60 mL/min/1.73m² | The most important kidney function summary marker. eGFR below 60 requires physician attention and potential protein target adjustment. Optimal eGFR above 90 confirms excellent kidney filtration capacity. |
Why Metabolic and Inflammatory Markers Must Be Read Together
Chronic inflammation and metabolic dysfunction are not separate problems — they are different expressions of the same underlying process. Elevated hs-CRP drives insulin resistance. Insulin resistance elevates triglycerides and lowers HDL, producing an inflammatory lipid environment. Elevated blood glucose glycates proteins and generates advanced glycation end products (AGEs) that directly trigger inflammatory signaling. This is why your PYW program treats metabolism and inflammation as a unified system.
- Falling hs-CRP + falling fasting insulin + falling HOMA-IR: The most powerful combined signal of program effectiveness. When these three move down together, the inflammatory-metabolic cycle is being interrupted at its root.
- Elevated hs-CRP + elevated triglycerides + low HDL: The classic inflammatory dyslipidemia triad. All three are driven by visceral fat and insulin resistance. All three respond to the same core interventions: fat loss, reduced refined carbohydrates, exercise, and sleep optimization.
- Falling liver enzymes (ALT, GGT) + falling hs-CRP: Confirmation that hepatic fat is being cleared and liver-produced inflammatory proteins are reducing simultaneously. This pattern typically appears within the first two quarterly panels on an active program.
- Elevated homocysteine + elevated hs-CRP: Dual vascular inflammation from both the methylation pathway (homocysteine) and systemic inflammatory cytokines (CRP). Address both simultaneously: B vitamin protocol for homocysteine and the full anti-inflammatory strategy for CRP.
- Normalized ferritin + normalized CRP: Confirms that previously elevated ferritin was inflammation-driven rather than true iron excess. As CRP falls, ferritin follows — no iron-specific intervention was needed.
| Biomarker | Wellness-Optimal | Standard Reference | Key Note |
|---|---|---|---|
| hs-CRP | < 0.5 mg/L | < 3.0 mg/L | Confirm "high-sensitivity" CRP was ordered — standard CRP misses clinically significant low-grade inflammation. Do not test during illness or in first 2 weeks post-injury. |
| Homocysteine | 4–7 μmol/L | 5–15 μmol/L | Standard upper limit of 15 carries substantial vascular risk. Responds well to methylfolate, B12, and B6 within 8–12 weeks. Consider MTHFR testing if level is elevated despite adequate B vitamins. |
| Ferritin (Men) | 75–150 ng/mL | 12–300 ng/mL | Always interpret alongside hs-CRP. Elevated ferritin + elevated CRP = inflammation-driven. Elevated ferritin + normal CRP = potential iron excess. |
| Ferritin (Women) | 50–100 ng/mL | 12–150 ng/mL | Low ferritin (<20) is common on weight management programs. Symptoms: fatigue, hair thinning, exercise intolerance. Discuss supplementation with physician before attributing to program. |
| Total WBC | 4.5–7.5 K/μL | 4.5–11.0 K/μL | Upper portion of standard range (7.5–11.0) without infection signals chronic inflammation. Lower within-range WBC is associated with better metabolic outcomes. |
| NLR (Neutrophil/Lymphocyte) | 1.0–1.9 | Not typically reported | Calculate: Neutrophils ÷ Lymphocytes. One of the most powerful inflammatory ratios from a routine CBC. Request at your next check-in. |
| ESR | 0–10 mm/hr (M) / 0–12 mm/hr (W) | 0–20 mm/hr (M) / 0–30 mm/hr (W) | Broader inflammation signal than CRP. Complements hs-CRP rather than replacing it. Standard ranges allow much higher values than wellness-optimal. |
| ALT | < 25 U/L | < 56 U/L | Best liver health marker. Normalizes within 12–24 weeks of fat loss on program. Transient early rise during rapid fat mobilization is normal — discuss with physician if concerned. |
| GGT | < 20 U/L | < 45 U/L | Most sensitive marker of alcohol stress and oxidative burden on the liver. Responds quickly to alcohol elimination. Standard upper limit is far above wellness-optimal. |
| eGFR | > 90 mL/min | > 60 mL/min | Critical for members on high-protein protocols. If below 60, discuss protein target with your physician. Adequate hydration (100+ oz/day) supports optimal kidney filtration. |
The Patterns That Matter Most
Inflammatory markers are most informative when read as a system across multiple markers and across consecutive quarterly panels. These are the patterns your PYW physician watches most closely:
- Falling hs-CRP + falling HOMA-IR + falling triglycerides across panels: The inflammatory-metabolic improvement trifecta. When all three trend down together, your program is interrupting the root drivers of cardiovascular and metabolic disease simultaneously. This is the most powerful combination of changes your quarterly panel can show.
- Elevated hs-CRP + elevated NLR + upper-range total WBC (without infection): High inflammatory immune activation driven by chronic metabolic stress. The combined signal of three immune markers in the inflammatory direction is a clear call for intensified anti-inflammatory protocol focus: visceral fat reduction, sleep quality, stress management, and alcohol elimination.
- Elevated homocysteine + elevated hs-CRP + low HDL: Triple vascular risk signal. Each marker represents a different pathway of endothelial damage. Address the B vitamin deficiency driving homocysteine, the lifestyle factors driving CRP, and the insulin resistance driving low HDL — all are independently actionable.
- Elevated ALT + elevated GGT + elevated hs-CRP (without alcohol): Metabolic fatty liver driving hepatic inflammation. Visceral fat reduction is the primary intervention. Liver enzymes typically normalize before body weight reaches its ultimate target — metabolic improvement leads aesthetic improvement.
- Low ferritin + unexplained fatigue + normal hs-CRP: Iron depletion, not inflammation, is the cause of fatigue. This pattern requires iron assessment and potential supplementation — not further intensification of anti-inflammatory strategies that would not address the root cause.
- Normalizing hs-CRP + still-elevated NLR: Systemic inflammation is reducing, but the immune cell ratio is lagging. This often reflects ongoing stress, inadequate sleep, or a slower resolution of visceral fat. Prioritize sleep optimization and stress management as the next protocol focus.